Inhalation Sciences Sweden AB (publ) releases Q2 Report 2021
(Stockholm, Sweden, 26, August, 2021) Inhalation Sciences AB announces that the company's Q2 Report for 2021 (in Swedish) is now available on the company's website.For more information please visit: http://inhalation.se/investors/finansiella-rapporter/ Summary of the interim report ISAB submitted an application for the clinical validation of PreciseInhale in early April and received approval from the Swedish Medical Products Agency to begin the study at the end of May 2021. All 12 patients are now recruited, and the study is scheduled to be finalised before the end of the year. The